Assets Changement Date
Assertio Holdings USD 380.03M 25.15M 2023-09
Astellas Pharma JPY 3.54T 745.06B 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Cara Therapeutics USD 115.34M 19.05M 2023-09
Heron Therapeutics USD 229.2M 27.98M 2023-09
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
J&J USD 166.06B 25.62B 2023-09
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Omeros USD 493.07M 34.35M 2023-09
Pacira USD 1.57B 39.92M 2023-12
Perrigo USD 10.76B 206.4M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Revance Therapeutics USD 532.49M 65.05M 2023-09
Supernus Pharmaceuticals USD 1.28B 7.49M 2023-12
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Xeris Pharmaceuticals USD 327.78M 994K 2023-09
Xoma USD 124.09M 1.57M 2023-09
Zoetis USD 14.29B 180M 2023-12



Pacira Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.